Metoo Fill+ Hyaluronic Acid Dermal Filler Comparison: A Professional Sourcing Guide

The choice of HA dermal fillers significantly impacts clinic offerings and patient suitability. Below is a comparative overview of Metoo Fill+, a product from Maypharm, alongside the Elasty Plus range from CHA Meditech, and Hyaldew from BioPlus Co., Ltd. These products represent prominent options within the South Korean dermal filler market, widely recognized by international professionals.

Metoo Fill+ is a single-phase cross-linked hyaluronic acid filler manufactured by Maypharm in South Korea. It is formulated for various aesthetic applications, providing options for addressing facial wrinkles, folds, and contouring needs. The product is typically presented in pre-filled syringes for professional administration.

Clinics sourcing Metoo Fill+ can benefit from volume-tiered pricing structures, such as illustrated discounts of 4% for 11 units, 5% for 21 units, 6% for 31 units, and 8% for 51+ units. This structure supports cost-effective procurement for larger inventory requirements. Professionals can explore the wider selection of products within the Hyaluronic acid dermal filler catalog to compare options.

The Elasty Plus series, developed by CHA Meditech, offers a range of HA fillers designed with varying viscoelastic properties to suit different aesthetic indications. Products like Elasty Plus 1CC and its non-lidocaine counterparts provide flexibility for practitioners. The series typically includes formulations for fine lines, medium wrinkles, and deeper volume restoration, often incorporating lidocaine for patient comfort during procedures.

Elasty Plus fillers are characterized by their consistent particle size and uniform gel structure, aiming for predictable and smooth integration into tissues. Their versatility makes them a common choice for clinics managing a broad spectrum of patient concerns, from subtle enhancements to significant facial contouring.

Hyaldew fillers, from BioPlus Co., Ltd., are often highlighted for their claims of extended duration, attributed to specific cross-linking technologies. This range includes variants tailored for different depths of injection and volumizing effects, from superficial to deep tissue augmentation. Professionals considering Hyaldew typically do so for patients seeking longer-lasting results.

The unique formulation aspects of Hyaldew aim to enhance its stability and resistance to degradation, contributing to its purported extended longevity. This characteristic can be a significant factor for clinics looking to offer products with reduced frequency of re-treatment.

When comparing Metoo Fill+, Elasty Plus, and Hyaldew, professionals assess several factors. Viscoelasticity and Particle Size play a role in how each filler performs; Metoo Fill+ offers general utility, while Elasty Plus provides a graded range. Hyaldew is distinct for its marketed extended duration, appealing to specific patient profiles.

Lidocaine Content is another consideration; while some Elasty Plus variants contain lidocaine, Metoo Fill+ and Hyaldew availability with or without lidocaine can vary by specific product line and regional market. Wholesale Pricing Models, as seen with Metoo Fill+'s tiered discounts, are crucial for managing inventory costs. For further comparison insights into other prominent fillers, review guides such as Dermalax Deep / Plus vs. Alternatives: A Professional Sourci.

Selecting the appropriate dermal fillers for your clinic's inventory involves aligning product characteristics with your patient demographic and practice focus. For clinics prioritizing cost-effectiveness with reliable, general-purpose HA fillers, Metoo Fill+ presents a strong option, especially with its volume-based pricing. Its consistent performance across common indications makes it a suitable foundational product.

Practices requiring a versatile range with specific formulations for various depths may lean towards the Elasty Plus series. For clinics aiming to differentiate by offering extended-duration solutions, Hyaldew's unique selling proposition is noteworthy. A balanced inventory often incorporates products from various profiles to meet a diverse set of patient needs and budget considerations, optimizing both clinical outcomes and operational efficiency.